Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide

Chin Med J (Engl). 2024 Dec 10. doi: 10.1097/CM9.0000000000003417. Online ahead of print.
No abstract available